BR112021017651A2 - Mutantes sinciciais oncolíticos de herpes simplex como potentes terapêuticas contra o câncer - Google Patents
Mutantes sinciciais oncolíticos de herpes simplex como potentes terapêuticas contra o câncerInfo
- Publication number
- BR112021017651A2 BR112021017651A2 BR112021017651A BR112021017651A BR112021017651A2 BR 112021017651 A2 BR112021017651 A2 BR 112021017651A2 BR 112021017651 A BR112021017651 A BR 112021017651A BR 112021017651 A BR112021017651 A BR 112021017651A BR 112021017651 A2 BR112021017651 A2 BR 112021017651A2
- Authority
- BR
- Brazil
- Prior art keywords
- herpes simplex
- syncytial
- mutants
- hsv
- cancer therapeutics
- Prior art date
Links
- 208000009889 Herpes Simplex Diseases 0.000 title abstract 2
- 239000012830 cancer therapeutic Substances 0.000 title abstract 2
- 230000000174 oncolytic effect Effects 0.000 title abstract 2
- 230000003389 potentiating effect Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 1
- 241000700584 Simplexvirus Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/869—Herpesviral vectors
- C12N15/8695—Herpes simplex virus-based vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00051—Methods of production or purification of viral material
- C12N2710/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818577P | 2019-03-14 | 2019-03-14 | |
| US201962932725P | 2019-11-08 | 2019-11-08 | |
| PCT/US2020/022806 WO2020186238A1 (en) | 2019-03-14 | 2020-03-13 | Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021017651A2 true BR112021017651A2 (pt) | 2021-11-16 |
Family
ID=72426047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021017651A BR112021017651A2 (pt) | 2019-03-14 | 2020-03-13 | Mutantes sinciciais oncolíticos de herpes simplex como potentes terapêuticas contra o câncer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12480097B2 (https=) |
| EP (1) | EP3937960A4 (https=) |
| JP (2) | JP7671253B2 (https=) |
| KR (1) | KR102933002B1 (https=) |
| CN (1) | CN113710259B (https=) |
| AU (1) | AU2020235140B2 (https=) |
| BR (1) | BR112021017651A2 (https=) |
| CA (1) | CA3132867A1 (https=) |
| IL (1) | IL286142B2 (https=) |
| SG (1) | SG11202109707VA (https=) |
| WO (1) | WO2020186238A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120380154A (zh) * | 2022-12-14 | 2025-07-25 | Eg427公司 | 改良型单纯疱疹病毒1型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL131212A0 (en) * | 1999-08-03 | 2001-01-28 | Yissum Res Dev Co | Recombinant virus and live-virus vaccines |
| WO2005005637A2 (en) * | 2003-05-09 | 2005-01-20 | Medigene, Inc. | Herpes simplex virus comprising a genetically modified glycoprotein d |
| JP5639361B2 (ja) * | 2006-09-08 | 2014-12-10 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｈｓｖ−１及びｈｓｖ−２ワクチン並びにその使用方法 |
| JP6726824B2 (ja) * | 2013-07-17 | 2020-07-22 | ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション | 効率的な遺伝子送達用途のための非毒性ｈｓｖベクター及びその製造のための補完細胞 |
| JP6865736B2 (ja) * | 2015-05-04 | 2021-04-28 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． | 腫瘍溶解性ｈｓｖ１ベクターおよび使用法 |
| US10596234B2 (en) | 2016-10-28 | 2020-03-24 | University Of Southern California | Compositions and methods to inhibit viral replication |
| JP7490365B2 (ja) * | 2017-03-09 | 2024-05-27 | シァメン・ユニヴァーシティ | 組み換え単純ヘルペスウイルス及びその使用 |
-
2020
- 2020-03-13 CN CN202080032165.0A patent/CN113710259B/zh active Active
- 2020-03-13 CA CA3132867A patent/CA3132867A1/en active Pending
- 2020-03-13 SG SG11202109707V patent/SG11202109707VA/en unknown
- 2020-03-13 BR BR112021017651A patent/BR112021017651A2/pt unknown
- 2020-03-13 US US17/438,877 patent/US12480097B2/en active Active
- 2020-03-13 AU AU2020235140A patent/AU2020235140B2/en active Active
- 2020-03-13 IL IL286142A patent/IL286142B2/en unknown
- 2020-03-13 JP JP2021553296A patent/JP7671253B2/ja active Active
- 2020-03-13 KR KR1020217031853A patent/KR102933002B1/ko active Active
- 2020-03-13 EP EP20769295.5A patent/EP3937960A4/en active Pending
- 2020-03-13 WO PCT/US2020/022806 patent/WO2020186238A1/en not_active Ceased
-
2024
- 2024-12-12 JP JP2024218272A patent/JP2025028186A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020235140A1 (en) | 2021-09-30 |
| JP2025028186A (ja) | 2025-02-28 |
| CN113710259A (zh) | 2021-11-26 |
| JP7671253B2 (ja) | 2025-05-01 |
| KR102933002B1 (ko) | 2026-03-04 |
| CN113710259B (zh) | 2024-12-31 |
| JP2022524379A (ja) | 2022-05-02 |
| IL286142B2 (en) | 2026-03-01 |
| EP3937960A4 (en) | 2023-03-29 |
| IL286142B1 (en) | 2025-11-01 |
| EP3937960A1 (en) | 2022-01-19 |
| SG11202109707VA (en) | 2021-10-28 |
| KR20210139306A (ko) | 2021-11-22 |
| CA3132867A1 (en) | 2020-09-17 |
| WO2020186238A1 (en) | 2020-09-17 |
| AU2020235140B2 (en) | 2026-03-26 |
| US12480097B2 (en) | 2025-11-25 |
| US20220154149A1 (en) | 2022-05-19 |
| IL286142A (en) | 2021-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021551241A1 (en) | Expansion of natural killer cells and ilc3 cells with novel aromatic compounds | |
| PE20110358A1 (es) | Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias | |
| AR089873A1 (es) | Vegetales resistentes al glifosato y metodos asociados | |
| BR112013000822A2 (pt) | método e método de duas etapas para a produção de uma população de células exterminadoras naturais (nk) ativadas, população de células nk ativadas e método para suprimir a proliferação de células tumorais | |
| MY200418A (en) | Targeted non-viral dna insertions | |
| NZ592726A (en) | Amnion derived adherent cells | |
| MX339769B (es) | Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos. | |
| BR112018007538A2 (pt) | células exterminadoras naturais e células ilc3 e usos das mesmas | |
| WO2005042728A3 (en) | Immortalized avian cell lines for virus production | |
| MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
| WO2022187288A3 (en) | Systems and methods for genome-wide annotation of gene regulatory elements linked to cell fitness | |
| NZ595792A (en) | Antibodies specific to cadherin-17 | |
| BR112021012616A2 (pt) | Cepa produtora de ergotioneína e método para triagem da mesma | |
| BR112021019349A2 (pt) | Células-tronco preparadas altamente funcionais | |
| WO2021195446A3 (en) | Methods and compositions for restoring stmn2 levels | |
| IN2015MN00436A (https=) | ||
| BR112021025116A2 (pt) | Células linfocíticas ativadas e métodos de uso das mesmas para tratar câncer e condições infecciosas | |
| WO2021231263A3 (en) | Nucleic acid amplification methods | |
| WO2023288007A3 (en) | Expansion of memory natural killer cells | |
| CL2010000774A1 (es) | Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso. | |
| BR112021017651A2 (pt) | Mutantes sinciciais oncolíticos de herpes simplex como potentes terapêuticas contra o câncer | |
| CR7686A (es) | Suplemento agricola seguro para el ambiente | |
| WO2021015615A8 (en) | Low density cell culture | |
| WO2019204494A3 (en) | Date palm medium compositions and methods | |
| ZA202006210B (en) | Plant expression enhancer |